---
title: "SEELOS THERAPEUTICS INC (SEELQ.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SEELQ.US/norm.md"
symbol: "SEELQ.US"
name: "SEELOS THERAPEUTICS INC"
parent: "https://longbridge.com/zh-CN/quote/SEELQ.US.md"
datetime: "2026-05-21T15:18:50.482Z"
locales:
  - [en](https://longbridge.com/en/quote/SEELQ.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SEELQ.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SEELQ.US/norm.md)
---

# SEELOS THERAPEUTICS INC (SEELQ.US) — 财务报表

## 利润表 (USD)

| 指标 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 1.98 | -26.21 | -100.67 | -444.27 | -858.56 |
| ROE | -22.34% | 31.99% | 68.25% | -108.24% | 347.84% |
| 营业收入 | 376000.00 | 579000.00 | 653000.00 | 406000.00 | 336000.00 |
| 净利润 | 1.71M | -2.66M | -5.45M | 10.50M | -29.50M |
| 营业利润 | -3.14M | -6.05M | -8.01M | -12.60M | -10.95M |
| 毛利率 | -100.80% | -508.81% | -4512.10% | 100.00% | -2352.68% |
| 净利率 | 454.79% | -460.10% | -835.07% | 2585.71% | -8778.57% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 2.38M | 3.61M | 5.42M | 6.22M | 11.89M |
| 权益乘数 | -0.0846 | -0.1091 | -0.1617 | -0.2045 | -0.2520 |
| 每股净资产 | -135.50 | -277.74 | -437.92 | -732.17 | -1458.83 |
| 资产周转率 | 0.2823 | 0.1449 | 0.1564 | 0.0663 | 0.0354 |
| 现金及短投 | 294000.00 | 524000.00 | 3.00M | 2.58M | 5.84M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 47000.00 | 62000.00 | 15000.00 | 30000.00 | 44000.00 |
| 净债务 | 9.86M | 12.61M | 11.23M | 14.32M | 9.50M |

## 现金流量表 (USD)

| 指标 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -972000.00 | -4.64M | -1.91M | -5.75M | -5.90M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 742000.00 | 2.17M | 2.32M | 2.49M | -2.31M |
| 自由现金流 | -3.31M | -4.55M | 2.15M | -28.49M | 13.88M |
| 现金流充裕率 | -525.41% | -353.27% | -88.72% | -304.34% | -255.36% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |